http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102015027462-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_448f8c8c395bc367f28833558250f22f |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K127-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 |
| filingDate | 2015-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed039504d9949f52c9d294758a9097fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faf8ffff65851c374e15c0d8ac292a70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_549026f97473e3fd562077bb11149ec5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1239df2c791e463bd78a77e20b36ae8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2acdf753c6909e450cdd5885eca4a5a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64e5e0ece20d14d9cd7ffc7e3497489b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3f64c1f839425d0cbdfb9f97ef5a1a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28b91fa43f0355cebb2160e0a8e8a9ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b88cd3c1f62754516e43ae38bf8f6aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e4265ee08414ae30fc9fdafbb8fd789 |
| publicationDate | 2017-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-102015027462-A2 |
| titleOfInvention | thermoreversible hydrogel nanoemulsion containing the essential oil of hyptis pectinata as analgesic |
| abstract | heat-reversible hydrogel nanoemulsion containing the essential oil of hyptis pectinata as an analgesic. The present patent application relates to the production of the heat-reversible hydrogel containing the essential oil of hyptiss pectinata as an analgesic. Chronic pain is defined as pain lasting longer than tissue healing or pain lasting more than six months, such as fibromyalgia (flvl) and neuropathic pain. Musculoskeletal pain syndromes, such as FM, can be difficult to treat, which remains a major challenge for modern medicine. Thus, new studies have turned to medicinal plants as sources of new drugs, due to the various discoveries and scientific evidence about the beneficial effects of such plants. Due to its heat-sensitive property, in addition to being safe and capable of forming heat-reversible hydrogels and mucoadhesives in aqueous media, pluronic f12? has been used. In this way, the nanoemulsion of h oil was studied. , the secretion (neo-oil] -i) in heat-reversible hydrogel. Experimental protocols were performed in snussf mice, subcutaneously, in a volume of u, 3 ml, at a concentration of 3%, where long-lasting analgesic action can be observed on the non-inflammatory chronic muscle pain model. pharmacological action and effect on the central nervous system of ne-eoh. |
| priorityDate | 2015-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.